Company / Gross Margin
TENAX THERAPEUTICS, INC. Gross Margin History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
-65.5%
FY2016
5-year range
-65.5% / 4.2%
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 4.2% to -65.5% over the past 2 years.
Based on SEC 10-K filings.
-65.5% in FY2016 with a 3-year CAGR of -79.0%.
Declined from 4.2% to -65.5% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -79.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, gross margin increased 0.0% year-over-year.
- Peak gross margin was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | -65.5% | +0.0% |
| FY2015 | -65.5% | -1674.0% |
| FY2014 | 4.2% | -69.3% |
| FY2013 | 13.5% | -86.5% |
| FY2012 | 100.0% | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026